CAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) today announced key management and board appointments in advance of the company’s planned separation, targeted for mid-October, ...
SUNRISE, Fla., June 18, 2026 /PRNewswire/ -- Transpire Bio Inc., an integrated, U.S.-based, clinical-stage biopharmaceutical company, announced today that its Chief Financial Officer, LaDuane Clifton, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results